Exosomes in Aesthetics Treatments | Do they Cause Cancer?

September 13, 2025

Nita McEvoy

The short answer: no, they do not. And certainly not Celltermi Revive NX exosomes..

It is one of the most common and understandable questions being asked in regenerative aesthetics right now.

When a technology moves from advanced biomedical research into aesthetic practice, curiosity is natural. Innovation should invite questions. The responsibility of a professional industry is to answer it with clarity and evidence.

The short answer is this:

An illustration representing exosome innovation in aesthetics, symbolising the balance between scientific progress and public concern.

To understand why, we need to understand what exosomes actually are.

Exosomes are microscopic extracellular vesicles released by cells as part of normal biological communication. Every healthy cell in your body releases them daily. They act as messengers, carrying proteins, lipids, and signalling molecules between cells to coordinate repair, control inflammation, promote regeneration, and maintain tissue homeostasis.

They are not growth hormones.
They are not rogue stimulators.
They are communication systems.

For more than forty years, pharmaceutical researchers have studied exosomes. Once dismissed as cellular waste, they are now recognised as highly sophisticated delivery vehicles for biological information.

Now here is where nuance matters.

Yes, cancer cells also release exosomes. But so do healthy cells. The presence of exosomes is not the issue. The source is.

Exosomes reflect the condition of the cell from which they originate. Healthy cells release regenerative, regulatory signals. Diseased cells release dysfunctional signals. This is why sourcing is the single most important factor in aesthetic applications.

In aesthetics, responsible systems use exosomes derived from healthy, rigorously tested laboratory sources.

Celltermi Revive NX exosomes are bacterially derived, not human-derived. They are cultivated from Lactobacillus paracasei, a commensal bacterium that naturally lives on and within the human body.

This detail is significant.

Lactobacillus paracasei is a single-stranded DNA probiotic organism that forms part of our normal microbiota. It plays a role in immune regulation, barrier integrity, and the balance of inflammation. Our bodies recognise this bacterium as beneficial. We rely on commensal bacteria like this to support gut health, skin function, and immune system stability.

This relationship is symbiotic.

A symbiotic relationship means both organisms benefit. Bacteria contribute to our biological balance, and our bodies provide an environment for them to thrive. These organisms are not foreign threats. They are part of our internal ecosystem.

Because Lactobacillus paracasei is recognised as non-pathogenic and beneficial, its derived exosomes are highly compatible when purified and processed correctly.

During manufacturing, DNA is removed. What remains are purified signalling vesicles without genetic material. No DNA is being introduced into the skin. There is no cell transplantation. There is no genetic manipulation.

Each batch of Celltermi Revive NX exosomes is cultivated under sterile laboratory conditions, purified, freeze-dried, and rigorously safety-tested. They are supplied for single-use only, reducing cross-contamination risks in clinics.

This bacterial derivation also avoids a concern sometimes associated with human-derived exosomes.

Human-derived exosomes are not permitted for aesthetic treatments in many regulatory environments. Aside from regulatory restrictions, they may carry a theoretical risk of immune response because they originate from donor human tissue. Even when screened, donor variability introduces biological complexity.

Bacterially derived systems eliminate that variability, because the source organism is a recognised commensal bacterium, and because DNA is removed during purification, the risk of immune activation is significantly reduced. The body recognises the biological context. It is not encountering foreign human cellular material.

This is why sourcing is not a minor technical detail. It is the foundation of safety.

So, where does the concern about cancer come from?

In oncology research, scientists study exosomes extensively. That research exists because exosomes play a role in cellular communication during both health and disease. They are being explored for their potential in regenerative medicine, immune modulation, and tissue recovery.

The research focus is on understanding and harnessing their regenerative signalling, not because they initiate cancer.

Exosomes do not multiply cells. They do not override cellular control mechanisms. They carry instructions that reflect their origin.

In aesthetic treatments, especially when paired with microneedling, this signalling becomes highly relevant.

Microneedling already triggers the skin’s natural healing cascade. Part of that cascade includes the release of endogenous exosomes from healthy cells as they coordinate repair. When Celltermi Revive NX exosomes are introduced alongside this process, the regenerative messaging is amplified. The skin receives additional support for collagen production, inflammation control, and tissue renewal.

The result is improved texture, refined pores, enhanced barrier function, and visible luminosity.

Unlike traditional hyaluronic acid skin boosters that primarily focus on hydration, Celltermi Revive NX exosomes operate at a cellular communication level. They support fibroblast signalling, collagen synthesis, and dermal strengthening. The effect is structural and regenerative rather than superficial.

Celltermi also holds the world’s only patented Nidogen-1 preservation formula, designed to protect the biological activity and stability of its exosome concentration. Each vial contains 150 billion bacterially derived vesicles produced under pharmaceutical standards by Cha Meditech, part of the globally respected CHA Bio Group in South Korea.

South Korea continues to lead in regenerative biotechnology and advanced medical research. This scientific infrastructure underpins the quality and safety behind the Celltermi system.

We are now entering an era in aesthetics that prioritises undetectable rejuvenation. Clients are moving away from exaggerated volume and toward skin-first strategies. Regenerative science aligns perfectly with this shift.

To summarise clearly:

  • Exosomes do not cause cancer.
  • Cancer cells release exosomes, but so do healthy cells. The source determines the signal.
  • Celltermi Revive NX exosomes are bacterially derived from a recognised commensal organism.
  • DNA is removed during processing.
  • They are purified, safety tested, and supplied for single use.
  • They are designed to support regeneration, not uncontrolled growth.

When discussing safety, clarity matters more than speculation.

Reliable information deserves to travel far.

If you are a qualified practitioner in microneedling or mesotherapy and wish to explore Celltermi Revive NX exosomes further, we offer a complimentary CPD opportunity with your first purchase.

Modern regenerative aesthetics is not about replacing biology. It is about understanding it.

And when we understand how cells communicate, we understand how skin heals.

And if you are a qualified practitioner in Microneedling & Mesotherapy and you’d like to dive deeper, enjoy a free CPD opportunity with your first purchase of Revive NX exosomes box of 5 sets.

Check out our range here → Shop

Follow Revive NX UK →

Instagram → @revivenx_uk

TikTok → @revivenx_uk

Nita McEvoy speaking on stage at IMCAS Paris 2026 during the Global Aesthetics Leaders Forum.

About Me| Nita MCEVoy

As Chief Executive Officer of Revive NX, Nita McEvoy leads a global regenerative aesthetics portfolio spanning biotechnology, education and distribution. An experienced practitioner and global trainer, she is committed to advancing structured, science led protocols that redefine modern aesthetic practice.

Leave a Comment

0
    0
    Your Cart
    Your cart is emptyReturn to Shop